# Brixmor Property Group Inc.: financial statements, quarterly

BRX · NYSE · CIK 1581068 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/brx.md) · [Financials](/companies/brx/financials.md) · [Filings](/companies/brx/filings.md) · [Insiders](/companies/brx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/brx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [316 d](/filings/0001581068-26-000007.md) | [320](/filings/0001581068-25-000021.md) | [316](/filings/0001581068-25-000030.md) | [321](/filings/0001581068-25-000040.md) | [328 d](/filings/0001581068-26-000007.md) | [338](/filings/0001581068-26-000021.md) | [339](/filings/0001581068-26-000026.md) | [341](/filings/0001581068-26-000031.md) | [354 d](/filings/0001581068-26-000007.md) | [355](/filings/0001581068-26-000021.md) | [354](/filings/0001581068-26-000026.md) | [360](/filings/0001581068-26-000031.md) |
| Interest expense | $m | [47.2 d](/filings/0001581068-24-000007.md) | [51.5](/filings/0001581068-24-000020.md) | [53.7](/filings/0001581068-24-000032.md) | [55.4](/filings/0001581068-25-000040.md) | [55.4 d](/filings/0001581068-26-000007.md) | [54.1](/filings/0001581068-26-000021.md) | [54.4](/filings/0001581068-26-000026.md) | [56.7](/filings/0001581068-26-000031.md) | [59.5 d](/filings/0001581068-26-000007.md) | [59.4](/filings/0001581068-26-000021.md) | [60.9](/filings/0001581068-26-000026.md) | [59.2](/filings/0001581068-26-000031.md) |
| Net income | $m | [72.7 d](/filings/0001581068-26-000007.md) | [88.9](/filings/0001581068-25-000021.md) | [70.1](/filings/0001581068-25-000030.md) | [96.8](/filings/0001581068-25-000040.md) | [83.4 d](/filings/0001581068-26-000007.md) | [69.7](/filings/0001581068-26-000021.md) | [85.1](/filings/0001581068-26-000026.md) | [94.2](/filings/0001581068-26-000031.md) | [137 d](/filings/0001581068-26-000007.md) | [128](/filings/0001581068-26-000021.md) | [73.5](/filings/0001581068-26-000026.md) | [87.8](/filings/0001581068-26-000031.md) |
| Diluted EPS | $ per share | not reported | [0.29](/filings/0001581068-25-000021.md) | [0.23](/filings/0001581068-25-000030.md) | [0.32](/filings/0001581068-25-000040.md) | not reported | [0.23](/filings/0001581068-26-000021.md) | [0.28](/filings/0001581068-26-000026.md) | [0.31](/filings/0001581068-26-000031.md) | not reported | [0.41](/filings/0001581068-26-000021.md) | [0.24](/filings/0001581068-26-000026.md) | [0.28](/filings/0001581068-26-000031.md) |
| Basic EPS | $ per share | not reported | [0.29](/filings/0001581068-25-000021.md) | [0.23](/filings/0001581068-25-000030.md) | [0.32](/filings/0001581068-25-000040.md) | not reported | [0.23](/filings/0001581068-26-000021.md) | [0.28](/filings/0001581068-26-000026.md) | [0.31](/filings/0001581068-26-000031.md) | not reported | [0.42](/filings/0001581068-26-000021.md) | [0.24](/filings/0001581068-26-000026.md) | [0.29](/filings/0001581068-26-000031.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.9](/filings/0001581068-26-000007.md) | [407](/filings/0001581068-25-000021.md) | [474](/filings/0001581068-25-000030.md) | [451](/filings/0001581068-25-000040.md) | [378](/filings/0001581068-26-000007.md) | [107](/filings/0001581068-26-000021.md) | [105](/filings/0001581068-26-000026.md) | [332](/filings/0001581068-26-000031.md) | [334](/filings/0001581068-26-000031.md) | [324](/filings/0001581068-26-000021.md) | [171](/filings/0001581068-26-000026.md) | [164](/filings/0001581068-26-000031.md) |
| Total assets | $m | [8,333](/filings/0001581068-25-000009.md) | [8,644](/filings/0001581068-24-000020.md) | [8,731](/filings/0001581068-24-000032.md) | [8,750](/filings/0001581068-24-000043.md) | [8,909](/filings/0001581068-26-000007.md) | [8,595](/filings/0001581068-25-000021.md) | [8,606](/filings/0001581068-25-000030.md) | [9,049](/filings/0001581068-25-000040.md) | [9,133](/filings/0001581068-26-000031.md) | [9,103](/filings/0001581068-26-000021.md) | [9,007](/filings/0001581068-26-000026.md) | [9,023](/filings/0001581068-26-000031.md) |
| Total liabilities | $m | [5,482](/filings/0001581068-25-000009.md) | [5,785](/filings/0001581068-24-000020.md) | [5,876](/filings/0001581068-24-000032.md) | [5,869](/filings/0001581068-24-000043.md) | [5,925](/filings/0001581068-26-000007.md) | [5,641](/filings/0001581068-25-000021.md) | [5,653](/filings/0001581068-25-000030.md) | [6,086](/filings/0001581068-25-000040.md) | [6,123](/filings/0001581068-26-000031.md) | [6,066](/filings/0001581068-26-000021.md) | [5,954](/filings/0001581068-26-000026.md) | [5,972](/filings/0001581068-26-000031.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [5,340](/filings/0001581068-26-000007.md) | [5,104](/filings/0001581068-25-000021.md) | [5,097](/filings/0001581068-25-000030.md) | [5,493](/filings/0001581068-25-000040.md) | [5,495](/filings/0001581068-26-000031.md) | [5,496](/filings/0001581068-26-000021.md) | [5,322](/filings/0001581068-26-000026.md) | [5,323](/filings/0001581068-26-000031.md) |
| Shareholders' equity | $m | [2,850](/filings/0001581068-25-000009.md) | [2,859](/filings/0001581068-25-000040.md) | [2,855](/filings/0001581068-25-000040.md) | [2,881](/filings/0001581068-25-000040.md) | [2,984](/filings/0001581068-26-000007.md) | [2,954](/filings/0001581068-25-000021.md) | [2,953](/filings/0001581068-25-000030.md) | [2,963](/filings/0001581068-25-000040.md) | [3,010](/filings/0001581068-26-000031.md) | [3,037](/filings/0001581068-26-000021.md) | [3,022](/filings/0001581068-26-000026.md) | [3,020](/filings/0001581068-26-000031.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [135 d](/filings/0001581068-26-000007.md) | [129](/filings/0001581068-25-000021.md) | [184 d](/filings/0001581068-25-000030.md) | [157 d](/filings/0001581068-25-000040.md) | [155 d](/filings/0001581068-26-000007.md) | [130](/filings/0001581068-26-000021.md) | [181 d](/filings/0001581068-26-000026.md) | [168 d](/filings/0001581068-26-000031.md) | [172 d](/filings/0001581068-26-000007.md) | [141](/filings/0001581068-26-000021.md) | [204 d](/filings/0001581068-26-000026.md) | [171 d](/filings/0001581068-26-000031.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [302](/filings/0001581068-24-000020.md) | [302](/filings/0001581068-24-000032.md) | [303](/filings/0001581068-24-000043.md) | [303](/filings/0001581068-25-000021.md) | [303](/filings/0001581068-25-000030.md) | [304](/filings/0001581068-25-000040.md) | [307](/filings/0001581068-26-000021.md) | [308](/filings/0001581068-26-000026.md) | [308](/filings/0001581068-26-000031.md) | [308](/filings/0001581068-26-000021.md) | [308](/filings/0001581068-26-000026.md) | [308](/filings/0001581068-26-000031.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 306,872,316 at 2026-10-01, from the cover of the [10-Q filed 2026-10-26](/filings/0001581068-26-000031.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 26, 2026, 16:20 ET. No prices; not investment advice.